Scientists at Inserm and Institut Pasteur has developed a prognostic test that can predict the efficacy of hepatitis C treatments has been developed. The commercialisation of the test is expected in 2011. This test can predict the treatment efficacy of pegylated-interferon and ribavirin

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.
"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!